Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $435M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| APGE | APOGEE THERAPEUTICS INC | 374,000 | $31.48M | 7.2% | $42.82 | +68.7% | COM | 03770N101 |
| VOR | VOR BIOPHARMA INC | 1,750,000 | $31.22M | 7.2% | $17.61 | -20.6% | COM NEW | 929033207 |
| ZURA | ZURA BIO LTD | 4,215,930 | $25.08M | 5.8% | $5.67 | +3.8% | CLASS A ORD SHS | G9TY5A101 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,750,000 | $24.32M | 5.6% | $3.96 | +252.9% | COM | 03237H101 |
| IBRX | IMMUNITYBIO INC | 3,000,800 | $23.02M | 5.3% | — | — | Put | 45256X103 |
| NKTR | NEKTAR THERAPEUTICS | 316,453 | $22.77M | 5.2% | $38.19 | +26.6% | COM NEW | 640268306 |
| SLGL | SOL-GEL TECHNOLOGIES LTD | 274,363 | $21.74M | 5.0% | $66.40 | 0.0% | SHS NEW | M8694L137 |
| ALMS | ALUMIS INC | 856,061 | $18.86M | 4.3% | $24.33 | 0.0% | COM | 022307102 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 220,000 | $16.05M | 3.7% | $84.00 | 0.0% | COM NEW | 10919W405 |
| ANNX | ANNEXON INC | 2,500,000 | $13.85M | 3.2% | $5.75 | 0.0% | COM | 03589W102 |
| KALV | KALVISTA PHARMACEUTICALS INC | 675,000 | $13.59M | 3.1% | $13.24 | +17.0% | COM | 483497103 |
| IMVT | IMMUNOVANT INC | 545,625 | $13.55M | 3.1% | $19.88 | +32.1% | COM | 45258J102 |
| JBIO | JADE BIOSCIENCES INC | 964,462 | $13.55M | 3.1% | $22.88 | -35.4% | COM NEW | 008064206 |
| CTNM | CONTINEUM THERAPEUTICS INC | 800,198 | $10.45M | 2.4% | $11.41 | +17.0% | CL A | 21217B100 |
| ZBIO | ZENAS BIOPHARMA INC | 524,066 | $10.25M | 2.4% | $21.89 | 0.0% | COM | 98937L105 |
| NGNE | NEUROGENE INC | 500,000 | $10.08M | 2.3% | $15.74 | +15.3% | COM | 64135M105 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 500,000 | $9.32M | 2.1% | $16.05 | 0.0% | CLASS A ORD | 61559X104 |
| CLYM | CLIMB BIO INC | 1,334,130 | $9.139M | 2.1% | $3.09 | +61.6% | COM | 28658R106 |
| ORKA | ORUKA THERAPEUTICS INC | 183,330 | $8.992M | 2.1% | $14.82 | +118.9% | COM | 687604108 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,200,000 | $8.688M | 2.0% | $5.44 | +53.9% | COM | 29842P105 |
| VERA | VERA THERAPEUTICS INC | 199,348 | $8.02M | 1.8% | $44.97 | 0.0% | CL A | 92337R101 |
| EVMN | EVOMMUNE INC | 325,000 | $7.472M | 1.7% | $18.78 | +17.1% | COM SHS | 30054Y107 |
| LBRX | LB PHARMACEUTICALS INC | 300,000 | $7.398M | 1.7% | $22.38 | 0.0% | COM SHS | 50180M108 |
| CMPX | COMPASS THERAPEUTICS INC | 1,350,000 | $7.141M | 1.6% | $6.00 | 0.0% | COM | 20454B104 |
| SCYX | SCYNEXIS INC | 7,554,347 | $6.927M | 1.6% | $0.73 | 0.0% | COM NEW | 811292200 |
| PALI | PALISADE BIO INC | 3,405,757 | $5.96M | 1.4% | $1.78 | 0.0% | COM | 696389402 |
| CNTX | CONTEXT THERAPEUTICS INC | 2,238,496 | $5.865M | 1.3% | $1.72 | +18.9% | COM | 21077P108 |
| RLMD | RELMADA THERAPEUTICS INC | 842,106 | $5.861M | 1.3% | $4.01 | 0.0% | COM | 75955J402 |
| SLN | SILENCE THERAPEUTICS PLC | 1,020,489 | $5.378M | 1.2% | $5.91 | — | ADS | 82686Q101 |
| UNCY | UNICYCIVE THERAPEUTICS INC | 796,558 | $5.241M | 1.2% | $6.18 | +3.7% | COM NEW | 90466Y202 |
| TENX | TENAX THERAPEUTICS INC | 327,307 | $5.234M | 1.2% | $13.50 | 0.0% | COM NEW | 88032L605 |
| PMN | PROMIS NEUROSCIENCES INC | 371,402 | $4.717M | 1.1% | $12.16 | 0.0% | COM SHS | 74346M505 |
| CGEM | CULLINAN THERAPEUTICS INC | 300,000 | $4.263M | 1.0% | $9.02 | +32.7% | COM | 230031106 |
| IMMX | IMMIX BIOPHARMA INC | 350,000 | $3.188M | 0.7% | $6.19 | 0.0% | COM | 45258H106 |
| RZLT | REZOLUTE INC | 951,809 | $2.903M | 0.7% | $4.03 | -24.0% | COM NEW | 76200L309 |
| PHVS | PHARVARIS N V | 82,800 | $2.339M | 0.5% | $22.18 | +20.6% | COM | N69605108 |
| HUMA | HUMACYTE INC | 3,750,000 | $2.275M | 0.5% | $1.07 | 0.0% | COM | 44486Q103 |
| GALT | GALECTIN THERAPEUTICS INC | 800,000 | $2.232M | 0.5% | — | — | Call | 363225202 |
| AVTX | AVALO THERAPEUTICS INC | 124,666 | $1.861M | 0.4% | $16.88 | -8.2% | COM NEW | 05338F306 |
| ALKS | ALKERMES PLC | 50,000 | $1.768M | 0.4% | $32.34 | 0.0% | SHS | G01767105 |
| AVXL | ANAVEX LIFE SCIENCES CORP | 521,300 | $1.6M | 0.4% | — | — | Call | 032797300 |
| IRD | OPUS GENETICS INC | 324,340 | $1.476M | 0.3% | $2.74 | 0.0% | COM | 67577R102 |